NEW YORK, Jan. 29, 2018 (GLOBE NEWSWIRE) -- On January 19, 2018, Safirstein Metcalf LLP and HGT Law commenced a shareholder “opt-out” lawsuit (“Lawsuit”) on behalf of a group of retail investors (“Investors”) against Valeant Pharmaceuticals International, Inc. (“Valeant”) (NYSE:VRX) and its senior officers for violations of federal securities laws.

Previously, on June 24, 2016, a class action complaint was filed in the U.S. District Court for the District of New Jersey, on behalf of a class consisting of all purchasers of the common stock of Valeant (“Class Action”).  The Investors have opted out of the Class Action to directly pursue their own claims.  To date, this Lawsuit is the only opt-out action that has been filed on behalf of retail investors.

A copy of the complaint filed by Safirstein Metcalf LLP and HGT Law on behalf of the Investors can be found at www.valeantshareholderlitigation.com   

If you purchased Valeant common stock during the Class Period and suffered losses of more than $200,000, then you may wish to consider opting out of the existing class action.  If you would like to learn about the options available to you, please call 1-800-221-0015, email info@SafirsteinMetcalf.com or visit www.valeantshareholderlitigation.com

The class action is brought on behalf of purchasers of Valeant equity securities and senior notes between January 4, 2013 and March 15, 2016 (the “Class Period”).

Company: Valeant Pharmaceuticals International, Inc.
Exchange: NYSE
Ticker: VRX
Class Period: 01/04/2013 – 03/15/2016
  

About Safirstein Metcalf LLP and HGT Law

Safirstein Metcalf LLP focuses its practice on shareholder rights. The law firm also practices in the areas of antitrust and consumer protection.  All of the Firm’s legal endeavors are rooted in its core mission: provide investor and consumer protection.  

HGT Law is a boutique commercial litigation firm based​ in New York.  The firm focuses on representing investors in securities litigation and corporate governance/derivative litigation.

Attorney advertising.  Prior results do not guarantee a similar outcome.

Safirstein Metcalf LLP
Peter Safirstein, Esq.
1250 Broadway
27th Floor
New York, NY  10001
1-800-221-0015